Avenue Therapeutics, Inc. - Common Stock (ATXI)
1.3600
+0.0400 (3.03%)
Avenue Therapeutics Inc is a pharmaceutical company focused on the development of innovative therapies for the treatment of various medical conditions, primarily within the realm of pain management
The company is dedicated to advancing its pipeline of drug candidates, leveraging scientific research and clinical expertise to address unmet needs in healthcare. Avenue Therapeutics aims to bring new options to patients and healthcare providers, with a commitment to improving quality of life through its therapeutic solutions.